Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
Clinical trial NCT03770273 · COMPLETED
Trial details
- NCT number
- NCT03770273
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2023-07-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.